Industry NewsClinical Diagnostics Dako Announces Collaboration on Development of PD-L1 Companion Diagnostic Test for Investigational Cancer Drug Opdivo® (nivolumab)
Product NewsClinical Diagnostics Dako and Omnyx Launch Digital Pathology Solution for Breast Cancer Diagnostics
Product NewsClinical Diagnostics FDA Approves Two Dako Assays as Companion Diagnostics for Genentech’s New Breast Cancer Medicine Kadcyla
Product NewsClinical Diagnostics Dako to Develop Companion Diagnostic Test for Amgen Cancer Drug Candidates
